Published in Biochemistry (Mosc) on April 01, 2008
Mammalian glycosylation in immunity. Nat Rev Immunol (2008) 2.74
Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med (2011) 1.99
Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J Cell Sci (2009) 1.26
Identification of a conserved glycan signature for microvesicles. J Proteome Res (2011) 1.14
Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells. Mol Biol Cell (2011) 0.95
The thymus microenvironment in regulating thymocyte differentiation. Cell Adh Migr (2010) 0.93
Post-translational modifications of exosomal proteins. Front Immunol (2014) 0.89
Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells. PLoS One (2013) 0.86
The two endocytic pathways mediated by the carbohydrate recognition domain and regulated by the collagen-like domain of galectin-3 in vascular endothelial cells. PLoS One (2012) 0.82
ICP-MS-based multiplex profiling of glycoproteins using lectins conjugated to lanthanide-chelating polymers. J Proteome Res (2009) 0.81
Effect of exogenous galectin-1 on leukocyte migration: modulation of cytokine levels and adhesion molecules. Int J Clin Exp Pathol (2010) 0.81
Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update. Glycoconj J (2016) 0.75
Proteome-wide identification of glycosylation-dependent interactors of Galectin-1 and Galectin-3 on mesenchymal retinal pigment epithelial cells. Mol Cell Proteomics (2017) 0.75
Occurrence of novel Cu(2+)-dependent sialic acid-specific lectin, on the outer surface of mature caprine spermatozoa. Glycoconj J (2014) 0.75
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology (1993) 2.27
Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs. Virology (1998) 1.60
Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology (1998) 1.42
H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors. Virology (2004) 1.34
Differences between HA receptor-binding sites of avian influenza viruses isolated from Laridae and Anatidae. Avian Dis (2003) 1.26
Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong. Avian Dis (2003) 1.26
Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology (1999) 1.09
Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein. Glycoconj J (1997) 1.06
GlycoChip: multiarray for the study of carbohydrate-binding proteins. Lab Chip (2003) 1.04
Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity. FEBS Lett (1990) 1.01
Design of carbohydrate multiarrays. Biochim Biophys Acta (2006) 0.99
Influenza virus neuraminidase: structure and function. Acta Naturae (2009) 0.98
Receptor specificity of H5 influenza virus escape mutants. Virus Res (2004) 0.96
Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides. Biochemistry (Mosc) (2006) 0.94
[The effect of losing glycosylation sites near the receptor-binding region on the receptor phenotype of the human influenza virus H1N1]. Mol Biol (Mosk) (2003) 0.92
Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus. Antiviral Res (2005) 0.91
Design of the blood group AB glycotope. Glycoconj J (2005) 0.90
Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev (2000) 0.88
Structure, functions, and biosynthesis of glycoconjugates of Leishmania spp. cell surface. Biochemistry (Mosc) (2010) 0.87
Hydrogel glycan microarrays. Anal Biochem (2005) 0.87
Association of prognosis in surgically treated lung cancer patients with cytometric, histometric and ligand histochemical properties: with an emphasis on structural entropy. Anal Quant Cytol Histol (1998) 0.86
Human influenza virus recognition of sialyloligosaccharides. FEBS Lett (1995) 0.86
Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. Histol Histopathol (1993) 0.85
Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication. Antiviral Res (1994) 0.85
Fucoidan inhibits leukocyte recruitment in a model peritoneal inflammation in rat and blocks interaction of P-selectin with its carbohydrate ligand. Biochem Mol Biol Int (1997) 0.84
Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies. Glycobiology (2000) 0.84
Correlation of expression of binding sites for synthetic blood group A-, B- and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur J Cancer (1994) 0.84
Scintillation proximity assay for E-, P-, and L-selectin utilizing polyacrylamide-based neoglycoconjugates as ligands. Anal Biochem (1998) 0.83
An E-selectin binding assay based on a polyacrylamide-type glycoconjugate. Anal Biochem (1996) 0.83
Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol (1996) 0.83
Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein. Atherosclerosis (2001) 0.83
Search for additional influenza virus to cell interactions. Glycoconj J (2006) 0.83
Sialoside-binding macrophage lectins in phagocytosis of apoptotic bodies. Biochemistry (Mosc) (2005) 0.82
Fluorescent assay for studying the substrate specificity of neuraminidase. Anal Biochem (2005) 0.82
Modified blood group A trisaccharide probes: synthesis and interaction with antibodies. Carbohydr Lett (2001) 0.81
High-resolution atomic force microscopy study of hexaglycylamide epitaxial structures on graphite. Langmuir (2011) 0.81
Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates. Transfus Clin Biol (1997) 0.81
Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection. Antiviral Res (2002) 0.81
A new combined computational and NMR-spectroscopical strategy for the identification of additional conformational constraints of the bound ligand in an aprotic solvent. Chembiochem (2000) 0.81
New feature of angiotensin-converting enzyme: carbohydrate-recognizing domain. J Mol Recognit (2000) 0.81
[Modification of the target cell surface with lipophilic glycoconjugates and interaction of the modified cells with natural killer cells]. Bioorg Khim (2004) 0.81
Monoclonal antibodies directed to the synthetic carbohydrate antigen Ley. Hybridoma (1994) 0.80
[Inhibitory activity of monomeric and polymeric selectin ligands]. Vopr Med Khim (2000) 0.80
Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure. Biochem Soc Trans (1995) 0.80
Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells. J Leukoc Biol (1999) 0.80
In vitro influence of lectins and neoglycoconjugates on the growth of three human sarcoma cell lines. J Cancer Res Clin Oncol (1999) 0.80
[Immunomodulating effects of alpha1-acid glycoprotein (orosomucoid) in cultured human peripheral blood lymphocytes]. Biull Eksp Biol Med (1994) 0.80
[The interaction of peripheral blood leukocytes with alpha1-acid glycoprotein, its carbohydrate chains and neoglycoconjugates]. Gematol Transfuziol (1996) 0.80
Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates. Glycoconj J (2004) 0.80
Preneoplasia-associated expression of calcyclin and of binding sites for synthetic blood group A/H trisaccharide--exposing neoglycoconjugates in human lung. Cancer Biochem Biophys (1997) 0.80
[Sulfated polysaccharides as inhibitors of receptor activity of P-selectin and P-selectin-dependent inflammation]. Vopr Med Khim (1998) 0.80
A novel pentaglycosylceramide in ostrich liver, IV4-beta-Gal-nLc4Cer, with terminal Gal(beta1-4)Gal, a xenoepitope recognized by human natural antibodies. Glycobiology (2000) 0.80
[Molecular forms of alpha-1-acid glycoprotein in human blood serum. Differences in levels of di-, tri-, and tetra-antennary N-linked carbohydrate chains]. Bioorg Khim (1991) 0.80
[Conjugates and carbohydrate chains of alpha 1-acid glycoprotein with polyacrylamide maintain the immunomodulating activity of native glycoprotein]. Bioorg Khim (1995) 0.80
Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer. Breast Cancer Res Treat (2005) 0.80
An enzyme-linked lectin assay for alpha1,3-galactosyltransferase. Anal Biochem (2000) 0.80
[A possible association of fatal pneumonia with mutations of pandemic influenza A/H1N1 sw1 virus in the receptor-binding site of the HA1 subunit]. Vopr Virusol (2010) 0.79
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997. Tumour Biol (1998) 0.79
[Effect of glycoforms of alpha1-acid glycoprotein on in vitro production of tumor necrosis factor and interleukin-1 by mononuclear leukocytes from human peripheral blood]. Biull Eksp Biol Med (1998) 0.79
Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model. Eur J Cancer (2000) 0.79
Pulmonary metastases of breast carcinomas: ligandohistochemical, nuclear, and structural analysis of primary and metastatic tumors with emphasis on period of occurrence of metastases and survival. J Surg Oncol (1998) 0.79
Human tandem-repeat-type galectins bind bacterial non-βGal polysaccharides. Glycoconj J (2013) 0.79
Binding sites for carrier-immobilized carbohydrates in the kidney: implication for the pathogenesis of Henoch-Schönlein purpura and/or IgA nephropathy. Nephrol Dial Transplant (1999) 0.79
Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. J Mol Recognit (1998) 0.79
Carbohydrate-based probes for detection of cellular lectins. Anal Biochem (1998) 0.79
Glycohistochemical characterization of vascular muscle cell destruction in CADASIL subjects by lectins, neoglycoconjugates and galectin-specific antibodies. Neuropathol Appl Neurobiol (2003) 0.78
Microcalorimetric indications for ligand binding as a function of the protein for galactoside-specific plant and avian lectins. Biochim Biophys Acta (1999) 0.78
Albumin-like glycoprotein from human fetal tissue. Biochem Mol Biol Int (1994) 0.78
Carbohydrate specificity of chicken and human tandem-repeat-type galectins-8 in composition of cells. Biochemistry (Mosc) (2011) 0.78
Lectin ligands: new insights into their conformations and their dynamic behavior and the discovery of conformer selection by lectins. Acta Anat (Basel) (1998) 0.78
[ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates]. Bioorg Khim (1997) 0.78
Expression of endogenous lectins (galectins, receptors for ABH-epitopes) and the MIB-1 antigen in esophageal carcinomas and their syntactic structure analysis in relation to post-surgical tumor stage and lymph node involvement. Anticancer Res (2001) 0.78
Simultaneous detection of endogenous lectins and their binding capacity at the single-cell level--a technical note. Folia Biol (Praha) (1999) 0.78
[1,6-Anhydro-N-Acetyl- beta-D-glucosamine in oligosaccharide synthesis: II. synthesis of a spacered Ley tetrasaccharide]. Bioorg Khim (2007) 0.77
Microscale synthesis of glycoconjugate series and libraries. Anal Biochem (2000) 0.77
Expression of lectin, interleukin-2 and histopathologic blood group binding sites in prostate cancer and its correlation with integrated optical density and syntactic structure analysis. Anal Quant Cytol Histol (1995) 0.77
Effect of semisynthetic analog of alpha(1)-acid glycoprotein on immunomodulatory and antiinflammatory activity of natural glycoprotein. Bull Exp Biol Med (2000) 0.77
Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity. Xenotransplantation (2001) 0.77
[Different receptor specificity of influence viruses from ducks and chickens and its reflection in the composition of sialosides on host cells and mucins]. Vopr Virusol (2006) 0.77
Monomeric and multimeric blockers of selectins: comparison of in vitro and in vivo activity. Biochemistry (Mosc) (2005) 0.77
Galectins promote the interaction of influenza virus with its target cell. Biochemistry (Mosc) (2011) 0.77
Solid-phase assays for study of carbohydrate specificity of galectins. Biochemistry (Mosc) (2010) 0.77
Fluorescent carbohydrate probes for cell lectins. Spectrochim Acta A Mol Biomol Spectrosc (2001) 0.76
Uncharged P-selectin blockers. Glycoconj J (2004) 0.76
Modification of the functional activity of neutrophils treated with acute phase response proteins. Biochemistry (Mosc) (1998) 0.76
In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation (1995) 0.76
[Synthesis of N-acetyllactosamine-containing oligosaccharides, galectin ligands]. Bioorg Khim (2007) 0.76
Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serum. Xenotransplantation (2001) 0.76
D-Arabinose Methabolism: Characterization of Bifunctional Arabinokinase/Pyrophosphorylase of Leishmania major. Acta Naturae (2009) 0.76
Hypotheses of the Origin of Natural Antibodies: A Glycobiologist's Opinion. Biochemistry (Mosc) (2015) 0.76
Changes in the repertoire of natural antibodies caused by immunization with bacterial antigens. Biochemistry (Mosc) (2011) 0.76
Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomas. J Neuropathol Exp Neurol (2001) 0.76
[Isolation and characteristics of galactose-binding lectins from human blood serum]. Bioorg Khim (1996) 0.75
Oligosaccharide-binding molecules on the surface of human hemopoietic and lymphoid cells. FEBS Lett (1992) 0.75
Microtiter particle agglutination test for diagnosis of leprosy. Int J Lepr Other Mycobact Dis (1992) 0.75